Cronos Group Inc. (CRON.TO)
| Previous Close | 2.8600 |
| Open | 2.8400 |
| Bid | 2.7900 x 0 |
| Ask | 2.8100 x 0 |
| Day's Range | 2.7500 - 2.9900 |
| 52 Week Range | 2.1450 - 4.8800 |
| Volume | |
| Avg. Volume | 277,877 |
| Market Cap | 1.063B |
| Beta (5Y Monthly) | 1.49 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Calliditas Therapeutics AB Sponsored ADR (CALT) Surges 16.1%: Is This an Indication of Further Gains?
Calliditas Therapeutics AB Sponsored ADR (CALT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Motley Fool
Why Marijuana Stocks Triumphed on Monday
Cannabis stocks have become quite the hot item on the stock exchange lately, a trend that stretched into Monday's trading. Canadian weed companies also landed well in positive territory, with Organigram (NASDAQ: OGI) advancing at an 18% clip and Cronos Group (NASDAQ: CRON) rising by 9%. It's no accident that these rises came just before the influential rules committee of the U.S. House of Representatives is set to meet on an appropriations bill.
- CoinDesk
Blockchain Developer Cronos Labs Kicks Off Search for Participants in $100M Accelerator Program
Cronos Labs has also signed up Google Cloud, Amazon Web Services and blockchain security specialists PeckShield and Certik as mentors for the program.
